Crescent Biopharma (CBIO) Earnings Date, Estimates & Call Transcripts $11.84 -0.16 (-1.33%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesSEC FilingsSustainabilityTrendsBuy This Stock Crescent Biopharma Earnings Summary Crescent Biopharma announced Q2 2025 earnings on July 31, 2025, reporting an EPS of -$4.93, which missed analysts' consensus estimates of -$2.69 by $2.24. With a trailing EPS of -$34.93, Crescent Biopharma's earnings are expected to grow next year, from ($0.16) to ($0.03) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportLatest Q2 2025 Earnings DateJul. 31EstimatedConsensus EPS (Jul. 31) -$2.69 Actual EPS (Jul. 31) -$4.93 Missed By -$2.24 Get Crescent Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Crescent Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Crescent Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.76-$0.76-$0.76Q3 20251-$0.80-$0.80-$0.80Q4 20251-$0.82-$0.82-$0.82 2025 3 -$2.38 -$2.38 -$2.38 Q1 20261-$0.91-$0.91-$0.91Q2 20261-$0.96-$0.96-$0.96Q3 20261-$0.64-$0.64-$0.64Q4 20261-$0.60-$0.60-$0.60 Crescent Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025-$2.69-$4.93 -$2.24-$4.93--8/17/2023Q2 2023-$7.00-$7.00--$0.07-- Crescent Biopharma Earnings - Frequently Asked Questions When did Crescent Biopharma announce their last quarterly earnings? Crescent Biopharma (NASDAQ:CBIO) last announced its quarterly earning data on Thursday, July 31, 2025. Learn more on CBIO's earnings history. Did Crescent Biopharma beat their earnings estimates last quarter? In the previous quarter, Crescent Biopharma (NASDAQ:CBIO) missed the analysts' consensus estimate of ($2.69) by $2.24 with a reported earnings per share (EPS) of ($4.93). Learn more on analysts' earnings estimate vs. CBIO's actual earnings. How much profit does Crescent Biopharma generate each year? Crescent Biopharma (NASDAQ:CBIO) has a recorded net income of -$37.88 million. CBIO has generated -$34.93 earnings per share over the last four quarters. What is Crescent Biopharma's EPS forecast for next year? Crescent Biopharma's earnings are expected to grow from ($0.16) per share to ($0.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies Geron Earnings Zenas BioPharma Earnings Myriad Genetics Earnings Lexicon Pharmaceuticals Earnings Rigel Pharmaceuticals Earnings Emergent Biosolutions Earnings Verastem Earnings XOMA Royalty Earnings Vanda Pharmaceuticals Earnings Codexis Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:CBIO) was last updated on 8/4/2025 by MarketBeat.com Staff From Our Partners[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBIO Stock Alerts